Brief: Samsung Epis Holdings Co Applies To Korea Food Ministry For Approval Of Pembrolizumab Biosimilar
10/08/2026 09:05
BRIEF-Samsung Epis Holdings Co Applies To Korea Food Ministry For Approval Of Pembrolizumab Biosimilar Samsung Epis Holdings Co Ltd 0126Z0.KS:
APPLIES TO KOREA FOOD MINISTRY FOR APPROVAL OF PEMBROLIZUMAB BIOSIMILAR
Source text: [ID:]
Further company coverage: 0126Z0.KS
Recent news on Samsung Epis Holdings
See all newsBrief: Samsung Epis Holdings Says Unit Samsung Bioepis Entered Into Exclusive Supply Agreement Under Brazilian Government Programme For Rare-Disease Treatment
Brief: Samsung Bioepis, Teva Expand Strategic Partnership To Advance Up To 6 Potential Biosimilar Candidates
Brief: Samsung Epis Holdings Co Applies To Korea Food Ministry For Approval Of Pembrolizumab Biosimilar
Brief: Samsung Epis Holdings Co Q2 Operating Profit 86.6 Billion Won, Down 3.6% Y/Y